A Randomized, Multicenter, Phase II Study of the Efficac

  • Yee, Douglas (PI)
  • Haddad, Tufia (Prior Principal Investigator)

Project: Research project

Project Details

Description

A Randomized, Multicenter, Phase II Study of the Efficacy and Safety of Trastuzumab-MCC-DM1 vs. Trastuzmab (Herceptin) and Docataxel (Taxotere) in Patients with Metastatic HER2-Positive Breast Cancer who have not received prior Chemotherapy for Metastati
StatusFinished
Effective start/end date12/8/0812/31/13

Funding

  • Genentech Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.